相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
Xi Cao et al.
FRONTIERS IN ONCOLOGY (2021)
Noninvasively immunogenic sonodynamic therapy with manganese protoporphyrin liposomes against triple-negative breast cancer
Huaqing Chen et al.
BIOMATERIALS (2021)
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Kai Tang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition
Lin Xia et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Neoantigen: A New Breakthrough in Tumor Immunotherapy
Zheying Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Synergistic Effect of Photothermally Targeted NIR-Responsive Nanomedicine-Induced Immunogenic Cell Death for Effective Triple Negative Breast Cancer Therapy
Vellingiri Yasothamani et al.
BIOMACROMOLECULES (2021)
Asynchronous blockade of PD-L1 and CD155 by polymeric nanoparticles inhibits triple-negative breast cancer progression and metastasis
Chuanrong Chen et al.
BIOMATERIALS (2021)
Cancer Immunotherapies: From Efficacy to Resistance Mechanisms - Not Only Checkpoint Matters
Shuyue Wang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Recent Progress on NIR-II Photothermal Therapy
Yunguang Zhang et al.
FRONTIERS IN CHEMISTRY (2021)
Advances in Magnetic Nanoparticle-Mediated Cancer Immune-Theranostics
Hung-Wei Cheng et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Enhancement of tumor lethality of ROS in photodynamic therapy
Lan Ming et al.
CANCER MEDICINE (2021)
Enhancing Triple Negative Breast Cancer Immunotherapy by ICG-Templated Self-Assembly of Paclitaxel Nanoparticles
Bing Feng et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
A phase 2 clinical trialassessing theefficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer
Alice Y. Ho et al.
CANCER (2020)
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
Peter Schmid et al.
LANCET ONCOLOGY (2020)
Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy
Weijing Yang et al.
ACS NANO (2020)
Model-based evaluation of the efficacy and safety of nivolumab once every 4 weeks across multiple tumor types
X. Zhao et al.
ANNALS OF ONCOLOGY (2020)
Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model
Huan Xu et al.
BIOMATERIALS (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
CTLA-4: From mechanism to autoimmune therapy
Arezoo Hosseini et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
K. G. K. Deepak et al.
PHARMACOLOGICAL RESEARCH (2020)
Structural insight into T cell coinhibition by PD-1H (VISTA)
Benjamin T. Slater et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Tumor intrinsic and extrinsic immune functions of CD155
Jake. S. O'Donnell et al.
SEMINARS IN CANCER BIOLOGY (2020)
Recent Development of Photothermal Agents (PTAs) Based on Small Organic Molecular Dyes
Shibo Lv et al.
CHEMBIOCHEM (2020)
Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
Tanja Stuber et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Understanding the Role of Innate Immune Cells and Identifying Genes in Breast Cancer Microenvironment
Israa Shihab et al.
CANCERS (2020)
Fucoidan-based, tumor-activated nanoplatform for overcoming hypoxia and enhancing photodynamic therapy and antitumor immunity
Chu-Hung Chung et al.
BIOMATERIALS (2020)
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
Chunxiao Li et al.
MOLECULAR CANCER (2020)
Clinical development and potential of photothermal and photodynamic therapies for cancer
Xingshu Li et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer
Christopher D. Pack et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
Vikas Jain et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Aleksandra Zielinska et al.
MOLECULES (2020)
Intercellular Adhesion Molecule-1 as Target for CAR-T-Cell Therapy of Triple-Negative Breast Cancer
Heng Wei et al.
FRONTIERS IN IMMUNOLOGY (2020)
Photothermal therapies to improve immune checkpoint blockade for cancer
Preethi B. Balakrishnan et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2020)
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Javier Cortes et al.
LANCET (2020)
Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
Karan Mediratta et al.
CANCERS (2020)
An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer via Photothermal Ablation and Immune Remodeling
Yuanyuan Cheng et al.
ACS NANO (2020)
Designing and Engineering of Nanocarriers for Bioapplication in Cancer Immunotherapy
Yanhua Li et al.
ACS APPLIED BIO MATERIALS (2020)
Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
Zili Gu et al.
PHARMACEUTICS (2020)
The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer
Xiaoxue Xie et al.
FRONTIERS IN IMMUNOLOGY (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
TIM3 comes of age as an inhibitory receptor
Yochai Wolf et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Multifunctional sonosensitizers in sonodynamic cancer therapy
Subin Son et al.
CHEMICAL SOCIETY REVIEWS (2020)
Advanced Photosensitizer Activation Strategies for Smarter Photodynamic Therapy Beacons
Benjamin M. d Luby et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Ana C. Garrido-Castro et al.
CANCER DISCOVERY (2019)
Targeting Treg cells in cancer immunotherapy
Atsushi Tanaka et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
Target selection for CAR-T therapy
Jianshu Wei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
Ru Zhou et al.
FRONTIERS IN IMMUNOLOGY (2019)
Transformable Nanoparticle-Enabled Synergistic Elicitation and Promotion of Immunogenic Cell Death for Triple-Negative Breast Cancer Immunotherapy
Chenfeng Xu et al.
ADVANCED FUNCTIONAL MATERIALS (2019)
Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer
Rui Zhang et al.
SMALL (2019)
Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy
Liping Huang et al.
NATURE COMMUNICATIONS (2019)
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
S. Adams et al.
ANNALS OF ONCOLOGY (2019)
Sonodynamic Therapy: Advances and Challenges in Clinical Translation
Maxime Lafond et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2019)
Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse
Katherine D. Cummins et al.
LEUKEMIA & LYMPHOMA (2018)
Metal-Organic-Framework-Derived Carbon Nanostructure Augmented Sonodynamic Cancer Therapy
Xueting Pan et al.
ADVANCED MATERIALS (2018)
Magnetic Field Changes Macrophage Phenotype
Jarek Wosik et al.
BIOPHYSICAL JOURNAL (2018)
Targeting the microenvironment in solid tumors
Carmen Belli et al.
CANCER TREATMENT REVIEWS (2018)
Nanoparticle-assisted ultrasound: A special focus on sonodynamic therapy against cancer
Giancarlo Canavese et al.
CHEMICAL ENGINEERING JOURNAL (2018)
Application of hyaluronic acid as carriers in drug delivery
Gangliang Huang et al.
DRUG DELIVERY (2018)
FOXP3+Treg as a therapeutic target for promoting anti-tumor immunity
Theresa L. Whiteside
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Kristian M. Hargadon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment
Xiaoyang Hou et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment
Samaresh Sau et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
Lina Liu et al.
MOLECULAR THERAPY (2018)
Liposomal Drug Delivery Systems and Anticancer Drugs
Temidayo O. B. Olusanya et al.
MOLECULES (2018)
High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer
Lijuan Wei et al.
FRONTIERS IN IMMUNOLOGY (2018)
Gold nanoparticles-induced cytotoxicity in triple negative breast cancer involves different epigenetic alterations depending upon the surface charge
Sunil Kumar Surapaneni et al.
SCIENTIFIC REPORTS (2018)
Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic
Samer Bayda et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Cemiplimab: First Global Approval
Anthony Markham et al.
DRUGS (2018)
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Rodabe N. Amaria et al.
NATURE MEDICINE (2018)
Breast Cancer Immunotherapy: An Update
Issam Makhoul et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2018)
T-Cell Immunoglobulin Mucin 3 Expression on Tumor Infiltrating Lymphocytes as a Positive Prognosticator in Triple-Negative Breast Cancer
Kyung Do Byun et al.
JOURNAL OF BREAST CANCER (2018)
Breast Cancer Immunotherapy: Facts and Hopes
Leisha A. Emens
CLINICAL CANCER RESEARCH (2018)
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
Lieve Brochez et al.
EUROPEAN JOURNAL OF CANCER (2017)
TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
Wenwen Du et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
Jianjun Gao et al.
NATURE MEDICINE (2017)
TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
Nicholas A. Manieri et al.
TRENDS IN IMMUNOLOGY (2017)
Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics
Nicolas Bertrand et al.
NATURE COMMUNICATIONS (2017)
Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
Hyun Tae Lee et al.
SCIENTIFIC REPORTS (2017)
Targeting neoantigens to augment antitumour immunity
Mark Yarchoan et al.
NATURE REVIEWS CANCER (2017)
Polylactic acid (PLA) controlled delivery carriers for biomedical applications
Betty Tyler et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Rita Nanda et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level
De-Gang Song et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment
Mingyue Li et al.
ONCOLOGY REPORTS (2016)
P-selectin is a nanotherapeutic delivery target in the tumor microenvironment
Yosi Shamay et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Pembrolizumab (Keytruda)
Gerry Kwok et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Recent advances of sonodynamic therapy in cancer treatment
Guo-Yun Wan et al.
CANCER BIOLOGY & MEDICINE (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Control of polymeric nanoparticle size to improve therapeutic delivery
John W. Hickey et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type
Zoran Gatalica et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Dendrimer as nanocarrier for drug delivery
Prashant Kesharwani et al.
PROGRESS IN POLYMER SCIENCE (2014)
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Iain A. Murray et al.
NATURE REVIEWS CANCER (2014)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
Rebecca Johnson et al.
Pharmaceutics (2013)
Inorganic nanoparticles for cancer imaging and therapy
Huang-Chiao Huang et al.
JOURNAL OF CONTROLLED RELEASE (2011)
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
Li Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
Impact of Nanotechnology on Drug Delivery
Omid C. Farokhzad et al.
ACS NANO (2009)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Drug delivery systems: Entering the mainstream
TM Allen et al.
SCIENCE (2004)
Biodegradable polymeric nanoparticles as drug delivery devices
KS Soppimath et al.
JOURNAL OF CONTROLLED RELEASE (2001)
分享论文
